News
06-03-2026, 06:33 PM
A large retrospective cohort study of 111,646 overweight or obese women found that GLP-1 agonist exposure was associated with lower breast cancer incidence. After propensity-score matching, GLP-1 exposure was linked to nearly 30% lower odds of breast cancer, but the authors stress that randomized trials are needed before these drugs can be considered for prevention.
More... (https://www.news-medical.net/news/20260603/Could-GLP-1-drugs-help-prevent-breast-cancer-New-study-points-to-a-possible-link.aspx)
More... (https://www.news-medical.net/news/20260603/Could-GLP-1-drugs-help-prevent-breast-cancer-New-study-points-to-a-possible-link.aspx)